{
    "Trade/Device Name(s)": [
        "Xpert MRSA/SA Blood Culture Assay",
        "Cepheid Xpert MRSA/SA Blood Culture Assay"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K101879",
    "Predicate Device Reference 510(k) Number(s)": [
        "K082140"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX"
    ],
    "Summary Letter Date": "July 2, 2010",
    "Summary Letter Received Date": "July 6, 2010",
    "Submission Date": "June 30, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)",
        "Staphylococcus aureus (SA) DNA"
    ],
    "Specimen Type(s)": [
        "Positive blood culture specimen"
    ],
    "Specimen Container(s)": [
        "BD BACTEC Plus Aerobic/F blood culture bottle"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Fluorogenic target-specific hybridization probe detection"
    ],
    "Methodologies": [
        "Molecular detection",
        "Real-time polymerase chain reaction (PCR)"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert MRSA/SA Blood Culture Assay using real-time PCR for rapid detection of MRSA and SA from positive blood cultures",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test to detect Staphylococcus aureus and methicillin-resistant Staphylococcus aureus DNA directly from positive blood cultures using the GeneXpert Dx System, as an aid in the detection of MRSA/SA, not intended to monitor treatment.",
    "fda_folder": "Microbiology"
}